Articles & Research from Venn Life Sciences

Technical Due Diligence

Technical due diligence (or gap analysis) is the process of thoroughly examining all aspects of a product, including identifying risks and confirming its value by meticulously reviewing documentation, information, data, records, and other relevant materials.

NONMEM Dataset Programming using SAS

Venn has a 15-year track record in offering PMx programming and translational modelling and simulation (M&S) services to the pharmaceutical industry. We are the preferred partner in clinical pharmacology to major pharma for both FSP and project-based engagements.

Quality Assurance

We integrate quality at every stage of product and service development. Our experience in navigating the complex regulatory landscape ensures that your processes align with current standards, and you are prepared for the foreseeable future demands.

Regulatory writing and project management in support of a United States Investigational New Drug application

A biotech company developing a treatment for cancer and immune disorders planned to conduct their Phase 1b clinical trial in the United States (US). They approached Venn Life Sciences seeking a partner to provide comprehensive support for their pre-Investigational New Drug (IND) meeting...

Venn capabilities for ATMPs

Venn Life Sciences, part of the hVIVO plc, is an Integrated Drug/ATMP Development Partner offering a unique combination of pre-clinical/CMC development expertise, clinical trial design and management. That enables to create, plan, and execute the development programs effectively and seamlessly for the clients.

Non-Clinical Pharmacokinetic Analysis

Venn Life Sciences was approached by a small biotech company to perform the non-compartmental pharmacokinetic analysis for one of their animal studies. Further to this they wanted to correlate exposure and other pharmacokinetic (PK) parameters with results of performed immunogenicity assays in the animals.

Accelerated timelines using dry run for clinical PKPD analyses

In this case study, Venn’s client requested an expedited timeline for a planned phase I/II oncology trial to secure regulatory submission deadline.

Integrated Drug Development Solution

How did Venn’s expertise and collaboration empower a small pharmaceutical company to overcome these challenges and breathe new life into a six-decade-old small molecule drug? In an ambitious endeavour, a small sized pharmaceutical company aimed to repurpose a small molecule drug that has been available...

« Previous 1 2 3 4 … 9 Next »